Literature DB >> 15885843

Electroporation and transcutaneous extraction (ETE) for pharmacokinetic studies of drugs.

S Narasimha Murthy1, Ya-Li Zhao, Sek Wen Hui, Arindam Sen.   

Abstract

The therapeutic activity and toxicity of drugs often depends on the accumulation of drugs in the peripheral anatomical compartment rather than the central compartment. In the routine practice of therapeutic drug monitoring (TDM) and pharmacokinetic studies, drug concentration determined by intermittent blood sampling is used as a surrogate for calculating the drug concentration in the peripheral compartment tissues. Microdialysis, a relatively less invasive procedure, has been used for estimation of free drug levels in dermal, subcutaneous and muscle tissues. Transcutaneous extraction of drugs from the dermal tissue is a good noninvasive alternative to phlebotomy and microdialysis. This requires a technique, which can facilitate the extraction of significant and reproducible amounts of drugs from the dermal extracellular fluid (ECF) within a short sampling duration. In the present work, we assessed the feasibility of electroporation and transcutaneous extraction (ETE) method for determining the time course of drugs in dermal ECF, using salicylic acid (SA) as a test drug. Electroporation protocol was optimized based on the in vitro diffusion studies of salicylic acid across rat skin. The concentration-time profile of total SA was determined in rats after a single i.v. bolus administration. The in vivo permeability coefficient (P(in vivo)) of rat skin was determined under steady state plasma concentration of drug created by i.v. bolus followed by constant rate infusion of SA. The pharmacokinetic parameters of the drug were determined using a two-compartment pharmacokinetic model. The theoretical predicted time course of free SA in the dermal ECF after a single i.v. bolus administration was calculated using standard formulae. The concentration of free SA determined by ETE is in good agreement with that calculated using two-compartment pharmacokinetic model. This study thus provides a credible evidence for the validity of ETE technique for determining the concentration of SA in the dermal ECF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885843     DOI: 10.1016/j.jconrel.2005.03.012

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

1.  Electroporation and transcutaneous sampling (ETS) of acyclovir.

Authors:  S Narasimha Murthy; Shuangqing Zhang
Journal:  J Dermatol Sci       Date:  2007-10-18       Impact factor: 4.563

2.  Calcein Release from Cells In Vitro via Reversible and Irreversible Electroporation.

Authors:  Violeta Rajeckaitė; Baltramiejus Jakštys; Arnas Rafanavičius; Martynas Maciulevičius; Milda Jakutavičiūtė; Saulius Šatkauskas
Journal:  J Membr Biol       Date:  2017-11-15       Impact factor: 1.843

3.  Glucose partition coefficient and diffusivity in the lower skin layers.

Authors:  Enam Khalil; Kosmas Kretsos; Gerald B Kasting
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

4.  Noninvasive transcutaneous sampling of glucose by electroporation.

Authors:  S Srinivasa Murthy; V Siva Ram Kiran; S K Mathur; S Narasimha Murthy
Journal:  J Diabetes Sci Technol       Date:  2008-03

5.  Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique.

Authors:  S M Sammeta; Siva Ram K Vaka; S Narasimha Murthy
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

6.  Transcutaneous sampling of ciprofloxacin and 8-methoxypsoralen by electroporation (ETS technique).

Authors:  Srinivasa M Sammeta; Siva Ram K Vaka; S Narasimha Murthy
Journal:  Int J Pharm       Date:  2008-11-05       Impact factor: 5.875

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.